Janson Beckett Cosmeceuticals Celebrates 4th Anniversary

CHERRY HILL, N.J.– – Janson Beckett Cosmeceuticals, a developer of peptide-based skin care treatments, marked its fourth anniversary of operation recently with the shipment of its 1,000,000th unit. Janson Beckett is best known for its top-selling topical BOTOX® alternative – AlphaDerma CE. To mark the milestone, the company announced the availability of DermaPlex EP – a gentle exfoliant that incorporates the popular peptide Matrixyl (Palmitoyl Pentapeptide). DermaPlex EP is expected to be a popular addition to Janson Beckett’s core regimen of peptide-based products that help repair problems associated with aging and damaged skin, such as fine lines, loss of firmness, and loss of radiance.